tm logo

Monitor this mark

View On USPTO

REXPLUS
Live/Registered
REGISTERED

on 19 Nov 2024

Last Applicant/ Owned by

Otsuka Pharmaceutical Co., Ltd.

Chiyoda-ku Tokyo 101-8535

JP

Serial Number

79392289 filed on 31st Jan 2024

Registration Number

7567806 registered on 19th Nov 2024

in the Principal Register

Correspondent Address

3-11-8, Higashi-Nihombashi,

Tokyo 103-0004,

JAPAN

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

REXPLUS

Pharmaceutical preparations for the treatment of central nervous system diseases and disorders

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of central nervous system diseases and disorders

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 79392289

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History

Status DateAction Taken
19th Dec 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
19th Nov 2024REGISTERED-PRINCIPAL REGISTER
03rd Sep 2024PUBLISHED FOR OPPOSITION
14th Aug 2024NOTICE OF PUBLICATION
01st Aug 2024APPROVED FOR PUB - PRINCIPAL REGISTER
29th Jul 2024ASSIGNED TO EXAMINER
09th Apr 2024APPLICATION FILING RECEIPT MAILED
03rd Apr 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01st Apr 2024LIMITATION FROM ORIGINAL APPLICATION ENTERED
28th Mar 2024SN ASSIGNED FOR SECT 66A APPL FROM IB